Caribou Biosciences, Inc. (CRBU)
1.97
+0.06
(+3.14%)
USD |
NASDAQ |
Mar 19, 16:00
1.96
-0.01
(-0.51%)
Pre-Market: 08:05
Caribou Biosciences Total Assets (Quarterly) : 179.63M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| EyePoint Plc | 364.00M |
| SELLAS Life Sciences Group, Inc. | 51.56M |
| GT Biopharma, Inc. | 8.106M |
| Aclaris Therapeutics, Inc. | 160.46M |
| CytomX Therapeutics, Inc. | 152.50M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 57.46M |
| Shareholders Equity (Quarterly) | 122.18M |
| Debt to Equity Ratio | 0.2229 |
| Current Ratio | 5.715 |
| Net Debt Paydown Yield | -0.08% |